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f o r i n f a n t s <2 y r s o f age and 250 mg b.i.d. f o r those >2 y r o l d . Compliance i s maximized by means o f r e g u l a r reminders. 7 1 p a t i e n t s have received PRO PCN f o r a t o t a l o f 204 person y r s . During t h e p a s t 6 112 y r s , 7 episodes o f S. pneumoniae bacteremia occurred i n 6 c h i l d r e n (3.4 eoisodes/100 person v r s ) ; 3 events were f a t a l S. neumoniae ' i n f e c t i o n s occurred i n 4 c l i n i c a l s e t t i n g s : il)+girl d i e d o f sepsis 13 months a f t e r we e l e c t f i e l y terminated 4 y r s o f prophylaxis. ( 2 ) A 14 month o l d g i r l d i e d o f sepsis 2 weeks a f t e r h e r PCN p r e s c r i pt i o n r a n o u t and h e r parents f a i l e d t o r e f i l l i t . ( 3 ) A f t e r missing o n l y 1 o r 2 doses, a 4 y r o l d g i r l d i e d and another o a t i e n t s u r v i v e d 2 eoisodes o f seosis. (41 Bacteremic oneumococcal pneumonia developed w i t h i n i 2 hours o f t h e l a s t P~N dose i n a 9 month o l d g i r l who was r e p o r t e d n o t t o have missed any r e c e n t doses. No examples o f PCN i n s e n s i t i v e o r r e s i s t a n t S. pneumoniae were seen. I n conclusion, PRO PCN may reduce t TZ frequency o f S. pneumoniae sepsis, b u t s t r i c t compliance i s required. Prolonged admini s t r a t i o n may be advisable, w i t h t h e understanding t h a t absolute p r o t e c t i o n i s n o t achieved. Treatment of idiopathic thrombocytopenic purpura (ITP) with high-dose intravenous immunoglobulins has been shown to be effective in several studies. It has not been demonstrated which part of the immunoglobulin molecule is decisive for the therapeutic effect. Based on a pilot study comparing 3.5 S, 5 S and 7 S-immunoglobulin (Ig) G which yielded treatment responses in each group, a prospective randomized study was conducted. This investigation compared a 7 S-IgG regimen to a 5 S-IgG regimen. The 7 S-IgG was prepared by limited sulfitolysis. The 5 S-F(ab)2-preparation was produced by pepsin cleavage. Thrombocytopenic patients (platelet counts <30x10~/1) were assigned to the treatment regimens randomly. Both groups were given 400 mg/kg body-weight Ig over 5 days. 9/10 patients in the 7 S treatment group responded to therapy compared to 3/10 patients in the 5 S treatment group (p = 0.0099 by Fisher's exact test). The mean platelet count 4 days after the last infusion was 209.52136.8 x 10~11 (3S.E.M.) in the 7 S group compared to 79.7275.0 x 10 /1 In the 5 S group. The results of the study emphasize the necessity of the IgG molecule's pFcpart, which is contained in the 7 S preparation. In patients with neutropenia, granulocytic reserve pools in the bone marrow are of diagnostic and prognostic relevance. This presentation describes a novel approach to the clinical assessment of neutropenia and reserve pool granulocytes. Based on previous studies in animals two different, highly purified polypeptide effectors were tested to mediate chemorecruitment of granulocytes from bone marrow: serum derived leukorecruitin (SLR, 8500 dalton) and monocyto-metamyelorecruitin (MMR, 6500 dalton) (Burdach et al. Fed. Proceed 1984, in press ). SLR mainly recruited mature, segmented granulocytes, thus causing a leukocytosis without a prominent left shift. MMR mainly caused recruitment of immature granulocytes in concurrence with sequestration of mature cells and, thus, resulted in a left shift and leukopenia. One trial with SLR in 1 healthy volunteer and 8 trials in 6 patients with disordered granulopoiesis were performed. The response in the control as well as in infantile agranulocytosis and constitutional aplastic anemia correlated with the cellular content of the bone marrow. However, in patients with preleukemia and hypersplenic pancytopenia, no correlation was observed; suggesting defective granulocyte kinetics. Two trials with MMR in 2 patients with inEantile agranulocytosis and osteopetrosis resulted in a storage pool depmdent release of immature granulocytes.
MECHANISM OF INTRAVENOUS IMMLTNOGLOBULIN TREATMENT

DETERMINATION OF GRANULOCYTE BONE MARROW STORAGE
~NTRAVENOUS GAMMAGLOBULIN VERSUS SPLENECTOMY IN
CHRONIC ITP: AN ANALYSIS OF BENEFITS AND COSTS. ~am2s
B. Bussel, John J. Ferry, J r . , Karen F. F i f e r , and Margaret W. H i l g a r t n e r , Dept. o f Peds. Cornell Med. C o l l . , New York H o s p i t a l , N.Y ., N.Y. IVGG has been used as an a l t e r n a t i v e t o splenectomy (SPL) i n c h i l d r e n < 14 years w i t h ITP f o r > 6 months ( J Peds 10183). Oec i s i o n a n a l y s i s was used t o compare the b e n e f i t s and c o s t s o f IVGG vs. SPL i n the i n i t i a l management o f chronic ITP. Published r e p o r t s and a survey o f 11 p e d i a t r i c hematology centers p r o v i d e d data f o r the a n a l y s i s . For IVGG, the experience o f the f i r s t 25 p a t i e n t s t r e a t e d a t Cornell was used: ( 1 ) THERAPY/COSTS: i n d u c ti o n IVGG dose o f 73 gramslpt ( 2 gms/kg) a t $40/gm=$3,000, avg maintenance IVGG dose i n a subsequent 6 month p e r i o d o f 117 gms/ p t $5,000, o f f i c e v i s i t s & CBC' s=$780. ( 2 ) OUTCOME/MANAGEMENT: 5 remissions, 6 s t a b l e w i t h o u t IVGG, 4 i n f r e q u e n t (<q2months) maintenance IVGG, 5 frequent maintenance IVGG, 5 r e f r a c t o r y ( w i t h subsequent response t o SPL n o t impaired). 60% p t s remission, p a r t i a l response: $1,000 f o r IVGG p a s t 12 months, 40% p t s f a i l i n g IVGG g e t SPL. For SPLENECTOMY: ( 1 ) COSTS: Surgery=$7000, admissions (two) f o r h i g h fever=$3,000, o f f i c e v i s i t and CBC's $220 ( 2 ) OUTCOME/MANAGEMENT: 80% r e m i s s i o n / p a r t i a l response, p t s f a i l i n g SPL g e t IVGG f o r 6 months ($8,780). The base case comparison y i e l d s costs o f $12,868 f o r IVGG and $11,976 f o r SPL, n e a r l y equal costs f o r the two s t r a t e g i e s . The major determinant v a r i a b l e s were the i n i t i a l c o s t o f surgery and the maintenance c o s t s o f c o n t i n u i n g IVGG. Bussel, and Margaret W. Hi1 g a r t n e r , Cornell Med Coll .
New York Hosp., Dept. Ped., NY, NY. P a r v i z L a l e z a r i , A1 b e r t E i n s t e i n C o l l . Med., Montefiore Hosp., Dept. Med., NY, NY. Senih M. F i k r i g , S t a t e Sch Med., Dept. Ped, Downstate Med Center, NY. P a t r i c i a A. F i t z e r a l d , Memorial Hosp., Dept Immunol ., NY, NY.
Autoimmune neutropenia o f i n f a n c y (ANI) i s a common, u s u a l l y benign disease ; c e r t a i n p a t i e n t s however have repeated and/or serious i n f e c t i o n s suggesting t h a t o t h e r immunologic abnormali t i e s could be present. W e i n v e s t i g a t e d 5 r e c u r r e n t l y ill p t s . w i t h absolute n e u t r o p h i l counts (ANC) < 200, and h i g h l e v e l a n t ineutrophi 1 antibodies. P r i o r t o treatment a1 1 p a t i e n t s had 4 0 % o f the n l IgG2 l e v e l and 4 0 % o f the n l IgG3 l e v e l s d e s p i t e n l t o t a l IgG l e v e l s . 3 o f 5 had decreased n a t u r a l k i l l e r a c t i v i t y t o K562 although 4 o f 5 had normal lymphocyte responses t o PHA. A l l 5 p a t i e n t s responded t o Intravenous Gammaglobulin (IVGG) a t a dose o f 2 t o 5 gm/kg (avg. 3 gm/kg) w i t h ANC >I000 w i t h i n 5 days and c l i n i c a l improvement. Neutrophil f u n c t i o n was n l i n 212 p t s t e s t e d a f t e r the ANC increased. A f t e r an average o f 10 m s . 4 p,ts. were i n remission and the f i f t h had an ANC o f 600. Natu r a l k i l l e r a c t i v i t y was n l i n 414 p a t i e n t s i n remission b u t IgG2 l e v e l s remained low i n 212 p a t i e n t s . AN1 may be associated w i t h IgG2 and/or IgG3 subclass d e f i c i e n c i e s and decreased natur a l k i l l e r a c t i v i t y which c o u l d e x p l a i n why these p t s . were p a r t i c u l a r l y ill. The NK a b o r m a l i t i e s resolved when t h e n e u t r op h i 1 a n t i bodies disappeared b u t IgG2 d e f i c i e n c y p e r s i s t e d . IVGG appeared t o have a l o n g e r l a s t i n g c l i n i c a l e f f e c t than t h e e l ev a t i o n o f the ANC ( 2 weeks).
